A modified glycosylase base editor without predictable DNA off‐target effects

Author:

Lian Meng12,Chen Tao3,Chen Min3,Peng Xiaohua3,Yang Yang4,Luo Xian3,Chi Yue3,Wang Jinling3,Tang Chengcheng3,Zhou Xiaoqing3,Zhang Kun3,Qin Chuan1,Lai Liangxue1234,Zhou Jizeng4,Zou Qingjian3ORCID

Affiliation:

1. Institute of Laboratory Animal Sciences Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China

2. Research Unit of Generation of Large Animal Disease Models Guangzhou China

3. Guangdong Provincial Key Laboratory of Large Animal Models for Biomedicine, South China Institute of Large Animal Models for Biomedicine, School of Biotechnology and Health Sciences Wuyi University Jiangmen China

4. CAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences Guangzhou China

Abstract

Glycosylase base editor (GBE) can induce C‐to‐G transversion in mammalian cells, showing great promise for the treatment of human genetic disorders. However, the limited efficiency of transversion and the possibility of off‐target effects caused by Cas9 restrict its potential clinical applications. In our recent study, we have successfully developed TaC9‐CBE and TaC9‐ABE by separating nCas9 and deaminase, which eliminates the Cas9‐dependent DNA off‐target effects without compromising editing efficiency. We developed a novel GBE called TaC9‐GBEYE1, which utilizes the deaminase and UNG‐nCas9 guided by TALE and sgRNA, respectively. TaC9‐GBEYE1 showed comparable levels of on‐target editing efficiency to traditional GBE at 19 target sites, without any off‐target effects caused by Cas9 or TALE. The TaC9‐GBEYE1 is a safe tool for gene therapy.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

National Key Research and Development Program of China Stem Cell and Translational Research

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3